Search by Drug Name or NDC
NDC 65197-0300-11 Gelusil 200; 24; 200; 1 mg/1; mg/1; mg/1; mg/1 Details
Gelusil 200; 24; 200; 1 mg/1; mg/1; mg/1; mg/1
Gelusil is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by WellSpring Pharmaceutical Corporation. The primary component is ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE; SILICON DIOXIDE.
MedlinePlus Drug Summary
Aluminum hydroxide is used for the relief of heartburn, sour stomach, and peptic ulcer pain and to promote the healing of peptic ulcers.
Related Packages: 65197-0300-11Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Aluminum Hydroxide
Magnesium hydroxide is used to treat occasional constipation in children and adults on a short-term basis. Magnesium hydroxide is in a class of medications called saline laxatives. It works by causing water to be retained with the stool. This increases the number of bowel movements and softens the stool so it is easier to pass.
Related Packages: 65197-0300-11Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Magnesium Hydroxide
Simethicone is used to treat the symptoms of gas such as uncomfortable or painful pressure, fullness, and bloating. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 65197-0300-11Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Simethicone
Product Information
| NDC | 65197-0300 |
|---|---|
| Product ID | 65197-300_775a4dcb-fa27-405a-8470-ccc5b2972a9f |
| Associated GPIs | 48991003100515 |
| GCN Sequence Number | 002708 |
| GCN Sequence Number Description | mag hydrox/aluminum hyd/simeth TAB CHEW 200-200-25 ORAL |
| HIC3 | D4B |
| HIC3 Description | ANTACIDS |
| GCN | 63951 |
| HICL Sequence Number | 001168 |
| HICL Sequence Number Description | MAGNESIUM HYDROXIDE/ALUMINUM HYDROXIDE/SIMETHICONE |
| Brand/Generic | Brand |
| Proprietary Name | Gelusil |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Alumina, Magnesia, Simethicone |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, CHEWABLE |
| Route | ORAL |
| Active Ingredient Strength | 200; 24; 200; 1 |
| Active Ingredient Units | mg/1; mg/1; mg/1; mg/1 |
| Substance Name | ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE; SILICON DIOXIDE |
| Labeler Name | WellSpring Pharmaceutical Corporation |
| Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M001 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65197-0300-11 (65197030011)
| NDC Package Code | 65197-300-11 |
|---|---|
| Billing NDC | 65197030011 |
| Package | 100 TABLET, CHEWABLE in 1 BOTTLE (65197-300-11) |
| Marketing Start Date | 2018-12-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |